Vivakor, Inc. 

(Public, OTC:VIVK)   Watch this stock   
Find more results for VIVK

Vivakor, Inc. discussed on blogs

Stock Market Analysis: Hot Penny Stocks 11/17/09 November 17, 2009 - tweid05@gmail.com (stockstobuy.org) - Stock Market Analysis - Nov 17, 2009

Vivakor, Inc. discussions

  View all discussions »

Description

Vivakor, Inc. (Vivakor) is a transdisciplinary research company that develops products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds. The Company also provides contract research services for third parties. It also performs contract research and development in molecular biology and devices engineering. This includes contracts to perform several studies to investigate and validate topical product claims. The Company’s research is dived into four primary areas: Molecular Medicine, Electro-Optics, Biological Handling and Natural and Formulary Products. On October 20, 2008, the Company acquired 84% of HealthAmerica, Inc.

Officers and directors

Matthew Nicosia
Executive Chairman of the Board
Age: 35
Tannin Fuja PhD
Chief Executive Officer, President, Chief Scientific Officer
Age: 33
Ed Corrente
Chief Financial Officer
Age: 47
John Gryga
Director